Glenmark's drug launch could be a game changer as it expands its presence in the high-value rare disease segment.
.jpeg "India Pharma Growth Broadens as Volumes Gain Momentum")
India’s pharma market shows balanced growth as rising volumes, steady pricing, and new launches drive sustained expansion across therapies and regions.
.jpeg "Hyderabad Emerges as Pharma R&D Hub with Neuland's $20M Bet")
Neuland’s $20M facility in Hyderabad strengthens Genome Valley’s position as a leading pharma innovation hub focused on advanced drug development.
Zydus Lifesciences has finalized its acquisition of Assertio Holdings, strengthening its position in the US specialty pharmaceutical market and expanding its presence across several high-value therapeutic segments.
The World Health Organization (WHO) has taken a major step toward improving child-focused dengue treatment with the publication of its first-ever Paediatric Drug Optimization Process (PADO) for dengue.
API prices are emerging as a key factor for India's pharmaceutical industry after a recent decline in the cost of active pharmaceutical ingredients (APIs).
Kiran Mazumdar-Shaw is placing one of Biocon's biggest bets on a market many pharmaceutical companies are no longer prioritizing. As global drugmakers rush to capitalize on the booming demand for GLP-1 and obesity drugs, the Biocon...
India’s respiratory disease surge is creating massive demand for treatments, and pharma companies are moving fast to meet it.
Centre mandates doctor prescriptions for cough syrups and syrup-based medicines, ending OTC sales and strengthening drug safety regulations nationwide.
Knee arthritis is a disease that plagues millions of Indians, often carrying an unspoken sentence, that of eventual knee replacement.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")